6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Bone Loss, Osteoclastic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cieslak, JA; Coates, RM; Fukura, S; Koohang, A; Lea, CR; Lee, HJ; Loftus, TC; Martin, MB; Matsumura, Y; Oldfield, E; Sagami, H; Sanders, JM; Sengupta, S; Szabo, CM | 1 |
| Bachmann, R; Bisping, M; Born, AR; Cortesi, R; Glatt, M; Green, JR; Guiglia, G; Jaeggi, KA; Jeker, H; Klein, R; Müller, K; Ramseier, U; Schmid, J; Schreiber, G; Seltenmeyer, Y; Widler, L | 1 |
| Celli, M; D'Eufemia, P; Finocchiaro, R; Lodato, V; Palombaro, M; Properzi, E; Villani, C; Zambrano, A | 1 |
| Bulleri, M; Di Munno, O; Giordani, R; Mazzantini, M; Metelli, MR | 1 |
| Benucci, M; Dolenti, S; Manfredi, M; Saviola, G | 1 |
| Baroni, MC; Costi, D; Mangoni, M; Maulucci, L; Pittari, G; Raballo, M | 1 |
| Casciari, C; Cristallini, S; Filipponi, P; Gregorio, F; Policani, G | 1 |
| Beneton, MN; Galloway, J; Harris, S; Kanis, JA; McCloskey, EV; Yates, AJ | 1 |
3 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers.
Topics: Aged; Amino Acids; Arthritis, Rheumatoid; Biomarkers; Blood Sedimentation; Bone Resorption; C-Reactive Protein; Collagen; Collagen Type I; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Male; Middle Aged; Peptides | 2002 |
[Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
Topics: Aged; Arthritis, Rheumatoid; Bone Resorption; Calcium; Data Interpretation, Statistical; Diphosphonates; Female; Follow-Up Studies; Glucocorticoids; Humans; Middle Aged; Osteoporosis; Polymyalgia Rheumatica; Sjogren's Syndrome; Time Factors; Treatment Outcome; Vitamin D | 2006 |
Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate.
Topics: Acute-Phase Reaction; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Drug Administration Schedule; Drug Resistance; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Peptides; Recurrence; Treatment Outcome | 1998 |
5 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates and diphosphates: a potential route to new bone antiresorption and antiparasitic agents.
Topics: Alkyl and Aryl Transferases; Antiparasitic Agents; Bone Resorption; Diphosphonates; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Models, Molecular; Organophosphates; Quantitative Structure-Activity Relationship; Recombinant Proteins | 2002 |
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
Topics: Animals; Bone Resorption; Calcitriol; Diphosphonates; Hypercalcemia; Imidazoles; In Vitro Techniques; Kidney; Mice; Pamidronate; Parathyroidectomy; Rats; Skull; Structure-Activity Relationship; Thyroidectomy; Zoledronic Acid | 2002 |
Serum brain-type creatine kinase increases in children with osteogenesis imperfecta during neridronate treatment.
Topics: Bone Resorption; Child; Child, Preschool; Creatine Kinase, BB Form; Densitometry; Diphosphonates; Female; Gene Expression Regulation, Enzymologic; Humans; Infusions, Intravenous; Male; Osteoclasts; Osteogenesis Imperfecta; Risk | 2014 |
Intravenous neridronate for skeletal damage treatment in patients with multiple myeloma.
Topics: Aged; Alkaline Phosphatase; Bone Density; Bone Resorption; Calcium; Diphosphonates; Female; Hip; Humans; Infusions, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Multiple Myeloma; Osteoclasts; Osteolysis; Safety; Time Factors; Treatment Outcome | 2006 |
Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man.
Topics: Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Organophosphonates; Paget Disease, Extramammary; Time Factors | 1987 |